IBX — Imagion Biosystems Income Statement
0.000.00%
Last trade - 00:00- AU$2.62m
- AU$2.79m
- AU$1.17m
Annual income statement for Imagion Biosystems, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.501 | 0.243 | 0.57 | 1.44 | 1.17 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 7.96 | 8.87 | 12.7 | 16.7 | 2.36 |
| Operating Profit | -7.45 | -8.63 | -12.1 | -15.3 | -1.18 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.36 | -6.02 | -9.81 | -12.5 | -2.07 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5.36 | -6.02 | -9.81 | -12.5 | -2.07 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.36 | -6.02 | -9.81 | -12.5 | -2.07 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.36 | -6.02 | -9.81 | -12.5 | -2.07 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.281 | -0.23 | -0.35 | -0.409 | -0.068 |